RESUMEN
Olfaction can increase the drive to eat and may partially explain the consistent increases in energy intake (EI) following sleep restriction. We investigated the effects of 50% sleep restriction with altered sleep timing on olfactory performance. We also evaluated whether changes (Δ) in olfactory performance were associated with Δ24 h EI. Twelve men and six women (age: 23±4 years; BMI: 23±3 kg/m2) completed three randomized cross-over conditions: habitual sleep duration, 50% sleep restriction with advanced wake-time, and 50% sleep restriction with delayed bedtime. Sleep was measured in-laboratory (polysomnography). Olfactory performance ('sniffin sticks') and 24 h EI (food menu) were evaluated the next day. A trend for a significant condition*sex interaction was noted for threshold-discrimination-identification (TDI) scores (P=0.09); TDI scores were lowest in women and highest in men, following sleep restriction with advanced wake-time. Δolfactory performance were not associated with Δ24 h EI. The impact of sleep restriction on olfactory performance may differ between sexes. Changes in olfactory performance were not associated with changes in 24 h EI. Studies investigating prolonged effects of sleep loss on the relationship between olfactory performance with EI are needed.
Asunto(s)
Percepción Olfatoria , Privación de Sueño/fisiopatología , Sueño/fisiología , Factores de Tiempo , Adulto , Índice de Masa Corporal , Estudios Cruzados , Dieta , Femenino , Humanos , Masculino , Polisomnografía , Tamaño de la Muestra , Adulto JovenRESUMEN
OBJECTIVE: To implement a treatment algorithm to operationalize treatment-resistance and improve patient outcomes in youth with pediatric bipolar disorder (PBD). The term "treatment resistance" was operationally defined as significant persistent symptoms following the application of a treatment algorithm. METHOD: Youth (6-17 years of age, n=120) with treatment-refractory bipolar I or II disorder, currently in a manic or mixed episode, were treated in accordance with the following 3 step algorithm: (1) removal of destabilizing agents (antidepressants, gamma aminobutyric acid [GABA]-agonists, and stimulants), (2) optimization of antimanic agents, and (3) use of a limited number (E 2) of mood stabilizers. The primary efficacy measure was change in scores on the Young Mania Rating Scale (YMRS) over the 6-month treatment course. Response was defined as repeated YMRS scores E 12. RESULTS: The sample was dichotomized into responders and non-responders. Both responders and non-responders improved significantly, with responders improving by a greater margin (d=3.2). At the end of 6 months, 75.8% of subjects demonstrated a significant and stable decrease in manic symptoms consistent with symptomatic remission (YMRS E 12). None of the subjects withdrew from the clinical process due to adverse events. CONCLUSION: The application of this proposed treatment algorithm allows for more accurate identification of true treatment resistance and can significantly reduce manic symptoms in patients previously described as having treatment-refractory bipolar disorder.
Asunto(s)
Síntomas Afectivos/tratamiento farmacológico , Antimaníacos , Trastorno Bipolar/tratamiento farmacológico , Guías de Práctica Clínica como Asunto , Adolescente , Antimaníacos/administración & dosificación , Antimaníacos/farmacocinética , Trastorno Bipolar/diagnóstico , Trastorno Bipolar/psicología , Niño , Monitoreo de Drogas , Resistencia a Medicamentos , Quimioterapia Combinada , Femenino , Humanos , Masculino , Administración del Tratamiento Farmacológico , Pacientes Ambulatorios , Escalas de Valoración Psiquiátrica , Inducción de Remisión , Factores de Tiempo , Resultado del TratamientoRESUMEN
OBJECTIVE: The aim of this study was to evaluate the tolerability and efficacy of rapid quetiapine loading in youth diagnosed with pediatric bipolar disorder (PBD). METHOD: Quetiapine was started at 100 mg/day, and increased to 400 mg/day by day 5 in 75 bipolar children (6-16 years), presenting in an acute manic or hypomanic episode. Subsequent dose adjustments were predicated on the clinical picture. Response was defined as a ≥ 50% reduction in baseline scores on the Young Mania Rating Scale (YMRS). Clinical Global Impression-Improvement Scale (CGI-I) scores of "2 much improved" or "1 very much improved" were used as secondary measures of response. Remission was defined as a YMRS score of ≤ 12. Adverse events, blood pressure, weight change, somnolence, extrapyramidal syndrome (EPS), and akathisia were monitored to determine tolerability. RESULTS: At 8 weeks, 94% of the sample had a CGI-I score ≤ 2, and 70% were in remission at 6 months. Sedation was reported by 50% of subjects during the first week; this rate dropped to 5.6% at 6 months. CONCLUSION: The findings indicate that rapid dose administration of quetiapine in children and adolescents with PBD is generally well tolerated and efficacious.
Asunto(s)
Antipsicóticos/administración & dosificación , Trastorno Bipolar/tratamiento farmacológico , Dibenzotiazepinas/administración & dosificación , Adolescente , Antipsicóticos/efectos adversos , Antipsicóticos/uso terapéutico , Enfermedades de los Ganglios Basales/inducido químicamente , Trastorno Bipolar/diagnóstico , Trastorno Bipolar/psicología , Niño , Dibenzotiazepinas/efectos adversos , Dibenzotiazepinas/uso terapéutico , Femenino , Humanos , Masculino , Escalas de Valoración Psiquiátrica , Fumarato de Quetiapina , Estudios Retrospectivos , Factores de Tiempo , Resultado del TratamientoRESUMEN
Rhodococcus equi is a common cause of pneumonia in animals. Human infection is rare. Increasing number of cases are being reported in immunosuppressed individuals mostly associated with HIV infection, but also in solid organ transplant recipients and leukemia/lymphoma patients. We report on an adult male who developed pneumonia and gastroenteritis 4 mo after receiving a renal transplant. CT scan of the lungs showed a dominant 2.5-cm upper lobe lung mass and smaller bilateral nodules. He underwent a diagnostic bronchoscopy with fine-needle aspiration biopsy of the largest lung nodule. Smears showed histiocytic granulomatous inflammation, foamy macrophages, and acute inflammatory exudate. Scattered foamy macrophages displayed intracellular coccobacilli identifiable on Diff-Quik stain. A few cells with changes suggestive of viral inclusions were identified. Cytomegalovirus (CMV) immunostain was positive in the cell block sections. Lung cultures grew R. equi. To the best of our knowledge, this is the first report of coinfection with R. equi and CMV.
Asunto(s)
Infecciones por Actinomycetales/diagnóstico , Infecciones por Citomegalovirus/diagnóstico , Trasplante de Riñón , Neumonía Bacteriana/diagnóstico , Neumonía Viral/diagnóstico , Complicaciones Posoperatorias , Rhodococcus/aislamiento & purificación , Infecciones por Actinomycetales/complicaciones , Infecciones por Actinomycetales/tratamiento farmacológico , Adulto , Antibacterianos , Antiinfecciosos/uso terapéutico , Antígenos Virales/análisis , Antivirales/uso terapéutico , Azitromicina/uso terapéutico , Biopsia con Aguja , Citomegalovirus/inmunología , Citomegalovirus/aislamiento & purificación , Citomegalovirus/patogenicidad , Infecciones por Citomegalovirus/complicaciones , Infecciones por Citomegalovirus/tratamiento farmacológico , Ganciclovir/uso terapéutico , Humanos , Huésped Inmunocomprometido , Masculino , Ofloxacino/uso terapéutico , Neumonía Bacteriana/tratamiento farmacológico , Neumonía Bacteriana/etiología , Neumonía Viral/tratamiento farmacológico , Neumonía Viral/etiología , Rhodococcus/metabolismo , Rhodococcus/patogenicidad , Tomografía Computarizada por Rayos X , Vancomicina/uso terapéuticoRESUMEN
Nine totally sleep deprived (TSD) and nine control subjects were evaluated with a complete battery for attention and memory performance. Frontal and temporal EEGs (5 min, eyes closed) were also recorded before and after the night. TSD subjects exhibited three performance deficits: learning the Pursuit Rotor Task, implicit recall of paired words, and distractibility on the Brown-Peterson Test. Relative to evening recordings, control subjects showed decreased morning absolute powers in all electrodes for all frequencies except for Frontal delta; TSD subjects showed increased Frontal and Temporal theta and Frontal beta. These results show that motor procedural, implicit memory, and working memory are sensitive to one night of TSD, and that Frontal and Temporal theta spectral power seem to discriminate between a night with sleep from a night without.
Asunto(s)
Trastornos del Conocimiento/etiología , Electroencefalografía , Trastornos de la Memoria/etiología , Privación de Sueño/psicología , Adulto , Trastornos del Conocimiento/diagnóstico , Femenino , Lóbulo Frontal/fisiopatología , Humanos , Masculino , Trastornos de la Memoria/diagnóstico , Lóbulo Temporal/fisiopatologíaRESUMEN
Abnormalities in serotonin levels have been implicated in a wide range of psychiatric disorders. Tryptophan 2,3-dioxygenase is the rate-limiting enzyme in the catabolism of tryptophan, the precursor of serotonin. As such it is a potential major candidate gene in psychiatric genetics. The regulatory, intron, and exon regions of the human TDO2 gene have been sequenced. Twelve exons were identified. The amino acid sequence of the enzyme was 88% homologous to that of the rat. Compared to the rat, the regulatory region of the human TDO2 gene had an insertion of approximately 1064 bp of random DNA beginning at -293 bp and extending to -1357 bp. This displaced the glucocorticoid response element (GRE) occurring at -1174 bp in the rat to -1500 in the human. The proximal GRE at -419 in the rat was missing in the human. However, within the DNA insert there was a GRE-like microsatellite region containing multiple GTT repeats plus additional GT(n) sequences. This could produce several staggered regions of the sequence TGTTGTnnnTGTTGT similar to a GRE consensus sequence of TGTTCAnnnTGTTCT. The intron regions 5' and 3' to each exon were sequenced This showed a HIS --> Val mutation polymorphism in exon 7. Three introns, 1,5, and 6, were completely sequenced and examined for polymorphism. This identified two polymorphisms consisting of G -- >T and G --> A mutations 2 bp apart in intron 6. The 3' end of intron 5 showed an extensive CCCT pentanucleotide repeat that was markedly polymorphic. These polymorphisms allow the TDO2 gene to be examined for a possible role in psychiatric disorders.
Asunto(s)
Hígado/enzimología , Secuencias Reguladoras de Ácidos Nucleicos , Secuencias Repetitivas de Ácidos Nucleicos , Triptófano Oxigenasa/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Sitios de Unión , Clonación Molecular , Secuencia de Consenso , ADN , Exones , Glucocorticoides/farmacología , Humanos , Intrones , Datos de Secuencia Molecular , Mutación , Reacción en Cadena de la Polimerasa , Ratas , Homología de Secuencia de Ácido Nucleico , TATA Box , Triptófano Oxigenasa/biosíntesisRESUMEN
The increased susceptibility of hypertrophied myocardium to ischemic injury is well known. Hypertrophied hearts possess lower preischemic high energy phosphate stores and develop ischemic contracture following a shorter ischemic interval than normal hearts. The purpose of this study was to determine the ability of preischemic, arrested perfusion of the hypertrophied rat heart with oxygenated, glucose-containing perfluorocarbon cardioplegia (FC-43) to restore myocardial ATP stores to normal and prolong the duration of global ischemia prior to contracture initiation. Hearts from normal (NL) rats and hypertrophied hearts from spontaneously hypertensive rats (SHR) were subjected to 2 or 15 min of preischemic, arrested perfusion with FC-43 utilizing a modified Langendorff preparation. ATP was determined via HPLC and time to initiation of ischemic contracture was measured. Two minutes of FC-43 perfusion restored ATP in the SHR group to normal levels (P = NS compared to normal controls) and prolonged the time to initiation of ischemic contracture by 107%. Perfluorocarbons, with their unique oxygen-carrying properties, may be an ideal vehicle for intervention designed to enhance the tolerance of hypertrophied hearts to ischemia.
Asunto(s)
Enfermedad Coronaria/metabolismo , Fluorocarburos/administración & dosificación , Adenosina Trifosfato/metabolismo , Animales , Cardiomegalia/metabolismo , Enfermedad Coronaria/fisiopatología , Masculino , Contracción Miocárdica , Perfusión , Ratas , Ratas Endogámicas SHRRESUMEN
A 3 1/2-year-old child had a murmur of pulmonary stenosis. Echocardiography and cardiac catheterization revealed a pulmonary infundibular obstruction. Magnetic resonance imaging of the heart demonstrated a mass in the interventricular septum. The mass was successfully resected and a pathologic diagnosis of capillary hemangioma was made. Only two previous cases of hemangioma causing right ventricular outflow obstruction have been reported; both of these cases involved adults. This case represents the first report of a hemangioma causing right ventricular outflow tract obstruction in a child. An exploratory operation with resection is the treatment of choice.